BIB
NASDAQ
Leveraged
$99.50
PROSHARES ULTRA NASDAQ BIOTECHNOLOGY (BIB)
Sector:
Healthcare
Net assets
$84M
Inception date
April 6, 2010
Sharpe Ratio
1.72
Price Chart
Valuation
Net assets$84M
P/S7.09
P/B5.22
Profitability
Profit Margin2.9%
Operating Margin-413.4%
Financial Health
Debt-to-Equity67.7%
Growth & Risk
Beta (5Y)1.49
Sharpe Ratio1.72